Obesity trials in South Korea

In South Korea 36 Also abroad 1939

36 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
Daegu, Daejeon, Gwangju, Gyeonggi-do, Incheon, Seongnam-si, Seoul
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Daejeon, Gangwon-do, Gwangju, Gyeonggi-do, Seongnam-si, Seoul
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
Phase 3Taking people
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Where
Anyang-si, Daejeon, Incheon, Seoul, Yangsan
Age
18 years and over
People
954 worldwide
Run by
Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00
Phase 3Taking people
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Where
Ansan-si, Anyang-si, Busan, Guri-si, Gwangju, Junggu, Seogu, Seongnam, Seongnam-si, Seoul
Age
18 years and over
People
2,001 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07794579 · EU 2026-526175-35-00
Phase 3Not yet taking people in South Korea
A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
Where
Anyang-si, Bucheon-si, Busan, Daegu, Daejeon, Seongnam-si, Seoul, Yangsan
Age
18 years and over
People
1,408 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07919405
Phase 3Taking people
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Where
Seongnam-si, Seoul
Age
6 years to 17 years
People
125 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06672549
Phase 3Taking people
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Where
Anyang-si, Bucheon-si, Busan, Gwangju, Junggu, Seoul
Age
18 years and over
People
1,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07202884 · EU 2025-522514-23-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Where
Ansan-si, Guri-si, Gwangju, Seongnam, Seoul
Age
18 years and over
People
1,035 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00
Phase 3Taking people
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Where
Daegu, Dongjak-gu, Seoul, Uijeongbu-si
Age
18 years and over
People
900 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07353931 · EU 2025-523768-19-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Where
Ansan-si, Seoul
Age
18 years and over
People
800 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07369011 · EU 2025-523769-11-00
Phase 3Taking people
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
Where
Seongnam-si, Seoul
Age
6 years to 11 years
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07817875 · EU 2025-522020-27-00
Phase 3Taking people
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Where
Ansan-si, Gwangju, Seongnam, Seoul
Age
18 years and over
People
1,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00
Phase 3Not yet taking people in South Korea
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Where
Ansan-si, Busan, Guri-si, Gwangju, Gyeongsan-si, Junggu, Namdong-gu, Seogu, Seongnam, Seongnam-si, Seoul
Age
18 years and over
People
2,115 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07881432 · EU 2026-526047-34-00
Phase 3Not yet taking people in South Korea
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
Bucheon-si, Busan, Guri-si, Gwangju, Gyeongsan-si, Incheon, Seogu, Seongnam, Seoul, Ulsan, Wŏnju
Age
45 years to 64 years
People
3,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Anyang, Bucheon-si, Daegu, Seoul, Yangsan
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Where
Daejeon, Gwangju, Seongnam-si, Gyeonggi-do, Seoul, Wonju-si, Gangwon-do
Age
18 years to 99 years
People
5,056 worldwide
Run by
Amgen
See details and how to joinNCT07037459
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Where
Busan, Daegu, Daejeon, Incheon, Seoul, Suwon
Age
18 years and over
People
1,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784270
Phase 3Taking people
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Where
Busan, Daegu, Goyang-si, Gyeonggi-do, Incheon, Jongno-gu, Seoul, Suwon
Age
18 years and over
People
4,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07667803
Phase 3Not yet taking people in South Korea
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
Where
Bucheon-si, Busan, Daegu, Daejeon, Gangwon-do, Gwangju, Gyeonggi-do, Incheon, Seongnam-si, Seoul, Suwon, Uijeongbu-si, Ulsan, Yangsan, Yŏngin
Age
45 years to 64 years
People
8,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00
No phaseEnrolling by invitation
WEgovy Real World Assessment of Weight Loss in Korea
Where
Busan, Daegu, Daejeon, Goyang-si, Gwangmyeong-si, Gyeonggi-do, Seongnam-si, Seongnam-si, Gyeonggi-do, Seoul, Suwon, Uijeongbu-si, Uijeongbu-si, Gyeonggi-do, Yangsan, Yongin-si
Age
19 years and over
People
500
Run by
Novo Nordisk A/S
See details and how to joinNCT07280221
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Where
Namdong-gu, Seogu, Seongnam, Seoul, Yangsan
Age
18 years and over
People
1,980 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00
No phaseTaking people
Agentic AI Personalized Dietary Management Study
Where
Seoul
Age
20 years to 90 years
People
200
Run by
Seoul National University Hospital
See details and how to joinNCT07638241
Phase 3Not yet taking people in South Korea
AMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Helps People in Asia With Excess Body Weight Lose Weight
Where
Daegu, Seoul, Seoungnam-si, Suwon, Yangsan
Age
18 years and over
People
400 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07668401
Phase 3Taking people
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Where
Anyang-si, Daegu, Daejeon, Gwangju, Incheon, Seongnam-si, Seoul, Suwon, Uijeongbu-si, Wŏnju, Yangsan
Age
18 years and over
People
5,610 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00
No phaseTaking people
Surgical TreAtment for Obesity Related Disease and Onco-Metabolic Surgery
Where
Seoul
Age
20 years to 69 years
People
120
Run by
Korea University Anam Hospital
See details and how to joinNCT04284943